SINK SIDE
NOTESSKIN-CARE DECISIONPRACTICAL CALL

U.S. ROUTINE CONTEXT · PRACTICAL CALL

Choose sunscreen for oily, blemish-prone skin without false blame

Compare shine, wear, cleansing, and formula evidence without assuming every breakout came from sunscreen.

NOTE 01

OUR SINK-SIDE CALL

The route we would take.

Trial one sunscreen and log the timing of reactions

NOTE 02

Where the call changes.

CHOOSE DIFFERENTLY WHEN

  • Stopping or under-applying sunscreen can be a larger harm than unwanted shine.
  • A breakout timeline alone does not identify the cause.

WHAT WE ARE NOT CLAIMING

  • Full SPF/UVA, film, real-use amount, cast by skin tone, water and sweat, and reapplication details are rarely public.

NOTE 03

HOW TO READ THIS NOTE

Evidence without theater.

This page makes an editorial call from documented context. It does not claim a product was owned, used, ranked, or independently tested. Manufacturer statements never become our results.

EVIDENCE TRAIL

What the sources carry — and what the desk decides.

The linked sources support product status, labeling, or professional boundaries. They do not prove the editorial winner and they do not stand in for an owned test.

EDITORIAL JUDGMENT

Trial one sunscreen and log the timing of reactions

A reasoned course of action; not a product result measured by the source.
BOUNDARY OF THE CALL

Stopping or under-applying sunscreen can be a larger harm than unwanted shine.

Full SPF/UVA, film, real-use amount, cast by skin tone, water and sweat, and reapplication details are rarely public.

Primary and professional sources in the record

  1. Is It a Cosmetic, a Drug, or Both? (Or Is It Soap?)U.S. Food and Drug Administration
  2. Cosmetics Labeling ClaimsU.S. Food and Drug Administration
  3. Summary of Cosmetics Labeling RequirementsU.S. Food and Drug Administration
  4. 21 CFR Part 701 — Cosmetic LabelingOffice of the Federal Register / eCFR
  5. Final Administrative Order OTC000039 — M020 Sunscreen Drug ProductsU.S. Food and Drug Administration
  6. 21 CFR 201.327 — OTC sunscreen labeling and effectiveness testingOffice of the Federal Register / eCFR
  7. Sunscreen: How to Help Protect Your Skin from the SunU.S. Food and Drug Administration
  8. Health Products Compliance GuidanceU.S. Federal Trade Commission
  9. 21 CFR Part 740 — Cosmetic Product Warning StatementsOffice of the Federal Register / eCFR
  10. FDA Adverse Event Monitoring System (AEMS)U.S. Food and Drug Administration
Data and test conditions still required
Product function and category

Document against the current U.S. product version; keep missing or non-comparable information visibly open.

Ingredient list for the current version

Document against the current U.S. product version; keep missing or non-comparable information visibly open.

Amount, contact time, and frequency

Document against the current U.S. product version; keep missing or non-comparable information visibly open.

SPF and UVA protection

Document against the current U.S. product version; keep missing or non-comparable information visibly open.

Sensory feel over time

Document against the current U.S. product version; keep missing or non-comparable information visibly open.

Evidence for the specific claim

Document against the current U.S. product version; keep missing or non-comparable information visibly open.

Tolerance protocol and stop criteria

Document against the current U.S. product version; keep missing or non-comparable information visibly open.

Audit sunscreen label and directions

Define and retain the conditions, date, material, and outcome before presenting any owned observation.

Assess sunscreen in the real routine

Define and retain the conditions, date, material, and outcome before presenting any owned observation.

Assess general tolerance with stop rules

Define and retain the conditions, date, material, and outcome before presenting any owned observation.

Trace a general claim to its evidence

Define and retain the conditions, date, material, and outcome before presenting any owned observation.